Consolidating close to the resistance.Given its recent FDA approvals ir.auriniapharma.com , we will see this breaking out in short time and head towards $30.
AUPH trade ideas
auph FDA approval retrace Spike from FDA approval. Anticipate pull back to 61 fib level. MT - price target is 61 feb extension level.
AUPH LONGLong on AUPH with entry around 15, just crossed over the 50ma on the 15m.
Patients treated with LUPKYNIS plus SoC were more than twice as likely to achieve renal response (RR) and experienced a decline in urine protein creatinine ratio (UPCR) twice as fast as patients on typical SoC alone.
Breakdown of gowngrade trendhave problem with 22 resistance but if break 22 can go to dynamic resistance 34 or static 39. stop loss 12.5
upside is coming for auph, on watchnice pullback/consolidation here for auph, look for a big breakout over the blue resistance area, if that breaks we can hit 20+ in early 2021 in my opinion. you can enter early here 14.8 , stop loss 13 and target 20+! leave a like/follow if you enjoy my ideas <3
$AUPHYear long pennant break out, should hit top of pennant within the next week ($22) then head toward $28
AUPH - BOUNCEIt looks like 12.81 has been a support level on four different occasions for AUPH. It also looks like the sell off is overblown with an RSI of 36. Im looking for a bounce up the fibonacci scale . $14.12 is my target over the next few trading days.
Finally broken downtrend channel...new highs on way!We've signaled that $15 breakout was coming...it has happened and maybe FDA approval is on way soon!
AUPH is above the last capital raise $15 and target is $21!!AUPH spent the summer as a bummer for all who bought the secondary at $15, but fall conferences ( OPCO on SEPT 23) will get the bystanders in this jewel which should eventually be bought out.
Looking for a breakout of this downward channel.A close today anywhere near 14.75 would virtually guarantee it. Target 18.40
AUPH: this one's gonna doubleAUPH is sitting on fib support here. Great spot to buy. Expecting this one to double.
$AUPH Aurinia Pharma Breakout Imminent
Looks like a perfect ABCDE correction is about to breakout.
Short term targets as per chart.
AUPH In a correction but will bounce to new highs soon. Hello,
What is AUPH?
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need.
News
Last week Aurinia Pharmaceuticals (NASDAQ: AUPH) announced that it completed a regulatory submission to the FDA seeking approval for its drug, voclosporin. If successful, vocolosporin could be the first FDA-approved treatment for lupus nephritis, an inflammatory kidney disease.
The company requested a Priority Review from the FDA, which would compress the agency's time to make a decision from 12 to eight months. The company is planning for a commercial launch in 2021.
The bigger picture includes the potential of voclosporin as a treatment for dry eye syndrome, which affects more than 16 million in the U.S. annually, and another kidney disorder called focal segmental glomerulosclerosis. Results from a late-stage clinical trial for dry eye syndrome are expected in the fourth quarter.
My thoughts
Looking at the chart I have identified a diagonal but have noted that wave 5 appears to have completed an ABC correction and might be in the process of creating an impulse as indicated on this chart. There are 3 key levels to watch for which will give us a clue of where the market wants to go. The first level is the corrective .50% and the .618% fib retracement level. The second level is support level 1 and the third level will be the bottom of wave 4 within this diagonal. Overall, giving the news, we know that if all the cards line up we will see new record highs for this stock come the new year. Beware that this stock could skyrocket way beyond what I have indicated on this chart as targets.
Good Luck, Cheers!
Be sure to comment, follow, like, and check out my profile for more trade ideas!
AUPH continues uptrend after stock dilution. All steam ahead.NASDAQ:AUPH will stabilize after the stock dilution and continue to its true value in the teens. Buy on the dip.
ir.auriniapharma.com
ir.auriniapharma.com
Does the motley fool help smart investors dunk on their readers?www.fool.com
Expecting this stock to pull back but the motley fool gives long advice.
